NCT00216346View on ClinicalTrials.gov

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis

PHASE3CompletedINTERVENTIONAL
Enrollment

667

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

November 30, 2004

Conditions
Visceral Leishmaniasis
Interventions
DRUG

Paromomycin sulfate

DRUG

Amphotericin B

Trial Locations (4)

800001

Kalazar Research Centre, Patna

842001

Kala-azar Medical Research Centre, Rambagh Road Muzaffarpur

842003

Kalazar Research Centre, Brahmpura, Muzaffarpur

800 007

Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agam Kuan, Patna

All Listed Sponsors
collaborator

World Health Organization

OTHER

lead

PATH

OTHER

NCT00216346 - Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis | Biotech Hunter | Biotech Hunter